Process for treatment of a lactic raw material
AssigneeNestec S.A.
InventorsPeter Erdmann, Fred Neumann
Life of this patent
Estimating the term…
Abstract
A process is disclosed for extracting glycomacropeptide from a lactic raw material. This process includes the step of treating a lactic raw material containing glycomacropeptide in the presence of a weakly anionic resin wherein the glycomacropeptide is selectively adsorbed onto the resin and then eluted from the resin so as to obtain an improved protein product which can be used in foods, and pharmaceutical and dental compositions.
Claims16
A process for obtaining a fraction of a lactic raw material enriched in glycomacropeptide or caseinoglycomacropeptide (“GMP”) comprising the steps of:
- deionizing a lactic raw material for a time sufficient to obtain a substantially deionized lactic raw material having a pH of about 1 to 4.5 with the pH being adjusted, if necessary, to the recited range;
- contacting the substantially deionized lactic raw material with an anionic resin having a hydrophobic matrix for a sufficient amount of time and at a sufficient temperature to adsorb a substantial amount of GMP onto the anionic resin from the substantially deionized lactic raw material and to obtain a treated liquid material that does not contain substantial, amounts of GMP;
- separating the resin from the treated liquid material;
- and
- separating the adsorbed GMP enriched fraction from the resin.
A process for obtaining a fraction of lactic raw material enriched in glycomacropeptide or caseinoglycomacropeptide (“GMP”) comprising the steps of:
- deionizing a lactic raw material for a time sufficient to obtain a substantially deionized lactic raw material having a pH of about 1 to 4.5 with the pH being adjusted, if necessary, to the recited range;
- contacting the substantially deionized lactic raw material with an anionic resin having a hydrophobic matrix for a sufficient amount of time and at a sufficient temperature to remove GMP from the substantially deionized lactic raw material and to obtain a treated liquid material, wherein the substantially deionized lactic raw material contacts the resin in a gently stirred reactor at a temperature of less than 50° C. for one to ten hours to adsorb the:
- GMP onto the resin;
- separating the resin from the treated liquid material;
- and
- separating the GMP enriched fraction from the resin.
A process for the extraction and removal of glycomacropeptide or caseinoglycomacropeptide (“GMP”) from a lactic raw material comprising the steps of:
- deionizing a lactic raw material for a time sufficient to obtain a substantially deionized lactic raw material having a pH of about 1 to 4.5 with the pH being adjusted, if necessary, to the recited range;
- contacting the substantially deionized lactic raw material with an anionic resin having a hydrophobic matrix for a sufficient amount of time and at a sufficient temperature to remove GMP from the substantially deionized lactic raw material by adsorbing a substantial amount of GMP onto the anionic resin to obtain a treated liquid material that does not contain substantial amounts of GMP;
- separating the resin from the treated liquid material;
- concentrating the treated liquid material by evaporation and drying;
- and
- recovering GMP by desorbing it from the resin.
A process for obtaining a fraction of a lactic raw material enriched in glycomacropeptide or caseinoglycomacropeptide (“GMP”) comprising the steps of:
- deionizing a lactic raw material for a time sufficient to obtain a substantially deionized lactic raw material having a pH of about 1 to 4.5 with the pH being adjusted, if necessary, to the recited range;
- treating the resin with an alkaline material;
- contacting the substantially deionized lactic raw material with an anionic resin having a hydrophobic matrix for a sufficient amount of time and at a sufficient temperature to adsorb a substantial amount of GMP onto the anionic resin from the substantially deionized lactic raw material and to obtain a treated liquid material that does not contain substantial amounts of GMP;
- separating the resin from the treated liquid material;
- and
- separating the adsorbed GMP enriched fraction from the resin.
A process for preparing a composition that contains glycomacropeptide or caseinoglycomacropeptide (“GMP”) in combination with a pharmaceutically acceptable carrier, said process comprising the steps of:
- (a) deionizing a lactic raw material for a time sufficient to obtain a substantially deionized lactic raw material having a pH of about 1 to 4.5 with the pH being adjusted, if necessary, to the recited range;
- (b) contacting the substantially deionized lactic raw material with an anionic resin having a hydrophobic matrix for a sufficient amount of time and at a sufficient temperature to adsorb a substantial amount of GMP onto the anionic resin from the substantially deionized lactic raw material and to obtain a treated liquid material that does not contain substantial amounts of GMP;
- (c) separating the resin from the treated liquid material;
- (d) separating the adsorbed GMP enriched fraction from the resin;
- and
- (e) combining the GMP of step (d) with a pharmaceutically acceptable carrier.
A process for obtaining a composition comprising a carrier and a fraction of a lactic raw material enriched in glycomacropeptide or caseinoglycomacropeptide (“GMP”), wherein said process comprises the steps of:
- deionizing a lactic raw material for a time sufficient to obtain a substantially deionized lactic raw material having a pH of about 1 to 4.5 with the pH being adjusted, if necessary, to the recited range;
- contacting the substantially deionized lactic raw material with an anionic resin having a hydrophobic matrix for a sufficient amount of time and at a sufficient temperature to adsorb a substantial amount of GMP onto the anionic resin from the substantially deionized lactic raw material and to obtain a treated liquid material that does not contain substantial amounts of GMP;
- separating the resin from the treated liquid material;
- separating the adsorbed GMP enriched fraction from the resin;
- and
- combining said GMP enriched fraction with a carrier;
- wherein said process the GMP enriched fraction includes less than 1% by weight of fat, less than 0.2% by weight of lactose, and less than 3% by weight of true whey products.
Dependencies are inferred from the claim text.